世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033720

世界のプロテオミクス市場-分析、規模、動向、COVID-19の影響、および2027年までの予測

Daedal Research

Global Proteomics Market: Analysis By Product, By Application, By Technology, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2027

発刊日 2022/12/06

言語英語

体裁PDF/172ページ

ライセンス/価格172ページ

0000033720

Single
2-5 Users
Corporate/Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界のプロテオミクス市場:製品別、用途別、技術別、エンドユーザー別、地域別規模&予測、およびCOVID-19の影響分析と2027年までの予測

概要

プロテオミクスは、疾患とその構造、機能、および発現に関与するタンパク質の研究です。生物の全タンパク質含有量のプロセスと相互作用を理解するのに役立ちます。プロテオミクス研究はまた、予後マーカーを特定し、マラリアや癌などの感染症の診断を可能にします。プロテオミクスは製薬業界でも使用され、薬物の作用や毒性のメカニズムを調べたり、バイオマーカーの有効性を特定および検証したりします。2021 年の世界のプロテオミクス市場は 249 億 8000 万ドルと評価され、2027 年までに 952 億 9000 万ドルに達する可能性があります。

技術の進歩、研究資金の増加、医療費の上昇、個別化された医薬品の需要の増加、上昇する遺伝性疾患の増加率も、今後数年間に市場の成長を促進すると予想されます。プロテオミクス市場は、2022 年から 2027 年までの予測期間中に 25% の CAGR で成長すると予想されます。.

レポート詳細

目次

1. Executive Summary

2. Introduction

2.1 Proteomics: An Overview
2.1.1 Proteomics Overview
2.1.2 Characteristics of Existing Proteomics Technologies

2.2 Proteomics Segmentation: An Overview
2.2.1 Proteomics Segmentation

3. Global Market Analysis

3.1 Global Proteomics Market: An Analysis

3.1.1 Global Proteomics Market: An Overview
3.1.2 Global Proteomics Market by Value
3.1.3 Global Proteomics Market by Product (Reagents, Instruments and Services)
3.1.4 Global Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
3.1.5 Global Proteomics Market by Technology (X-Ray crystallography, Surface Plasmon Resonance, Protein Fractionation, Electrophoresis, Protein Microarrays, Spectroscopy and Chromatography)
3.1.6 Global Proteomics Market by End Users (Pharmaceutical companies, Hospitals, Clinical laboratories, Academic research laboratories and others)
3.1.7 Global Proteomics Market by Region (North America, Europe, Asia Pacific and Rest of the World)

3.2 Global Proteomics Market: Product Analysis

3.2.1 Global Proteomics Market by Product: An Overview
3.2.2 Global Reagents Proteomics Market by Value
3.2.3 Global Instruments Proteomics Market by Value
3.2.4 Global Services Proteomics Market by Value

3.3 Global Proteomics Market: Application Analysis

3.3.1 Global Proteomics Market by Application: An Overview
3.3.2 Global Drug Discovery Proteomics Market by Value
3.3.3 Global Disease Diagnosis Proteomics Market by Value
3.3.4 Global Other Application Proteomics Market by Value

3.4 Global Proteomics Market: Technology Analysis

3.4.1 Global Proteomics Market by Technology: An Overview
3.4.2 Global X-Ray Crystallography Proteomics Market by Value
3.4.3 Global Surface Plasmon Resonance Proteomics Market by Value
3.4.4 Global Protein Fractionation Proteomics Market by Value
3.4.5 Global Electrophoresis Proteomics Market by Value
3.4.6 Global Protein Microarrays Proteomics Market by Value
3.4.7 Global Spectroscopy Proteomics Market by Value
3.4.8 Global Chromatography Proteomics Market by Value

3.5 Global Proteomics Market: End Users Analysis

3.5.1 Global Proteomics Market by End Users: An Overview
3.5.2 Global Hospitals Proteomics Market by Value
3.5.3 Global Clinical Laboratories Proteomics Market by Value
3.5.4 Global Pharmaceutical Companies Proteomics Market by Value
3.5.5 Global Academic Research Laboratories Proteomics Market by Value
3.5.6 Global Other End Users Proteomics Market by Value

4. Regional Market Analysis

4.1 North America Proteomics Market: An Analysis

4.1.1 North America Proteomics Market: An Overview
4.1.2 North America Proteomics Market by Value
4.1.3 North America Proteomics Market by Region (The US, Canada and Mexico)
4.1.4 The US Proteomics Market by Value
4.1.5 The US Proteomics Market by Application (Drug discovery, Disease diagnosis and others)
4.1.6 The US Drug Discovery Proteomics Market by Value
4.1.7 The US Disease Diagnosis Proteomics Market by Value
4.1.8 The US Other Proteomics Market by Value
4.1.9 Canada Proteomics Market by Value
4.1.10 Mexico Proteomics Market by Value

4.2 Europe Proteomics Market: An Analysis

4.2.1 Europe Proteomics Market: An Overview
4.2.2 Europe Proteomics Market by Value
4.2.3 Europe Proteomics Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
4.2.4 UK Proteomics Market by Value
4.2.5 Germany Proteomics Market by Value
4.2.6 France Proteomics Market by Value
4.2.7 Italy Proteomics Market by Value
4.2.8 Spain Proteomics Market by Value
4.2.9 Rest of Europe Proteomics Market by Value

4.3 Asia Pacific Proteomics Market: An Analysis

4.3.1 Asia Pacific Proteomics Market: An Overview
4.3.2 Asia Pacific Proteomics Market by Value
4.3.3 Asia Pacific Proteomics Market by Region (China, Japan, India, and Rest of Asia Pacific)
4.3.4 China Proteomics Market by Value
4.3.5 Japan Proteomics Market by Value
4.3.6 India Proteomics Market by Value
4.3.7 Rest of Asia Pacific Proteomics Market by Value

4.4 Rest of the World Proteomics Market: An Analysis

4.4.1 Rest of the World Proteomics Market: An Overview
4.4.2 Rest of the World Proteomics Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Proteomics Market
5.1.2 Post COVID-19 Impact

6. Market Dynamics

6.1 Growth Driver
6.1.1 Rising Prevalence of Cancer and Associated Genetic Disorder
6.1.2 Faster Turn-around Times (TAT)
6.1.3 Growth in Investments in Biotech Companies
6.1.4 Increased Investments in R&D in the Field of Proteomics
6.1.5 Accessibility and Reproducibility

6.2 Challenges
6.2.1 Dynamic Range
6.2.2 High Cost of Instruments
6.2.3 PTMs Explode the Level of Complexity in Proteomics

6.3 Market Trends
6.3.1 Artificial Intelligence in Proteomics
6.3.2 Surge in Drug Discovery
6.3.3 Emerging Method: High-Plex Proteomics
6.3.4 Emerging Technologies
6.3.5 Increasing Prominence Of Nanoprteomics
6.3.6 New Applications Based On Proteomics Technology Advancements

7. Competitive Landscape

7.1 Global Proteomics Market Players: Technology Comparison

8. Company Profiles

8.1 Danaher Corporation
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Agilent Technologies
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategy

8.3 PerkinElmer, Inc.
8.3.1 Business Overview
8.3.2 Operating Segments
8.3.3 Business Strategy

8.4 Bio-rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Thermo Fisher Scientific Inc.
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy

8.6 Bruker Corporation
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy

8.7 Illumina Inc.
8.7.1 Business Overview
8.7.2 Operating Segments
8.7.3 Business Strategy

8.8 Horiba, Ltd.
8.8.1 Business Overview
8.8.2 Operating Segments
8.8.3 Business Strategy

8.9 Waters Corporation
8.9.1 Business Overview
8.9.2 Operating Segments
8.9.3 Business Strategy

8.10 DiaSorin SpA (Luminex Corporation)
8.10.1 Business Overview
8.10.2 Revenue by Technology
8.10.3 Business Strategy

8.11 Promega Corporation
8.11.1 Business Overview
8.11.2 Business Strategy

List of Figures
Figure 1: Proteomics Segmentation
Figure 2: Global Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 3: Global Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 4: Global Proteomics Market by Product; 2021 (Percentage, %)
Figure 5: Global Proteomics Market by Application; 2021 (Percentage, %)
Figure 6: Global Proteomics Market by Technology; 2021 (Percentage, %)
Figure 7: Global Proteomics Market by End Users; 2021 (Percentage, %)
Figure 8: Global Proteomics Market by Region; 2021 (Percentage, %)
Figure 9: Global Reagents Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 10: Global Reagents Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 11: Global Instruments Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 12: Global Instruments Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 13: Global Services Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 14: Global Services Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 15: Global Drug Discovery Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 16: Global Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 17: Global Disease Diagnosis Proteomics Market by Value; 2021-2017 (US$ Billion)
Figure 18: Global Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 19: Global Other Application Proteomics Market by Value; 2017-2017 (US$ Billion)
Figure 20: Global Other Application Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 21: Global X-Ray Crystallography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 22: Global X-Ray Crystallography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 23: Global Surface Plasmon Resonance Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 24: Global Surface Plasmon Resonance Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 25: Global Protein Fractionation Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 26: Global Protein Fractionation Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 27: Global Electrophoresis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 28: Global Electrophoresis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 29: Global Protein Microarrays Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 30: Global Protein Microarrays Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 31: Global Spectroscopy Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 32: Global Spectroscopy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 33: Global Chromatography Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 34: Global Chromatography Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 35: Global Hospitals Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 36: Global Hospitals Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 37: Global Clinical Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 38: Global Clinical Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 39: Global Pharmaceutical Companies Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 40: Global Pharmaceutical Companies Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 41: Global Academic Research Laboratories Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 42: Global Academic Research Laboratories Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 43: Global Other End Users Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 44: Global Other End Users Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 45: North America Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 46: North America Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 47: North America Proteomics Market by Region; 2021 (Percentage, %)
Figure 48: The US Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 49: The US Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 50: The US Proteomics Market by Application; 2021 (Percentage, %)
Figure 51: The US Drug Discovery Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 52: The US Drug Discovery Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 53: The US Disease Diagnosis Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 54: The US Disease Diagnosis Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 55: The US Other Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 56: The US Other Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 57: Canada Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 58: Canada Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 59: Mexico Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 60: Mexico Proteomics Market by Value; 2022-2027 (US$ Million)
Figure 61: Europe Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 62: Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 63: Europe Proteomics Market by Region; 2021 (Percentage, %)
Figure 64: UK Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 65: UK Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 66: Germany Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 67: Germany Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 68: France Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 69: France Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 70: Italy Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 71: Italy Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 72: Spain Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 73: Spain Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 74: Rest of Europe Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 75: Rest of Europe Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 76: Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 77: Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 78: Asia Pacific Proteomics Market by Region; 2021 (Percentage, %)
Figure 79: China Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 80: China Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 81: Japan Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 82: Japan Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 83: India Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 84: India Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 85: Rest of Asia Pacific Proteomics Market by Value; 2017-2021 (US$ Million)
Figure 86: Rest of Asia Pacific Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 87: Rest of the World Proteomics Market by Value; 2017-2021 (US$ Billion)
Figure 88: Rest of the World Proteomics Market by Value; 2022-2027 (US$ Billion)
Figure 89: Global Artificial Intelligence Market Revenue; 2020-2024 (US$ Billion)
Figure 90: Danaher Corporation Sales by Segment; 2021 (Percentage, %)
Figure 91: Agilent Technologies Net Revenue by Business Segment; 2021 (Percentage, %)
Figure 92: PerkinElmer, Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 93: Bio-rad Laboratories, Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 94: Thermo Fisher Scientific Inc. Revenues by Segment; 2021 (Percentage, %)
Figure 95: Bruker Corporation Revenue by Segment; 2021 (Percentage, %)
Figure 96: Illumina Inc. Revenues by Segment; 2022 (Percentage, %)
Figure 97: Horiba, Ltd. Net Sales by Segments; 2021 (Percentage, %)
Figure 98: Waters Corporation Net Sales by Segments; 2021 (Percentage, %)
Figure 99: DiaSorin SpA (Luminex Corporation) Revenue by Technology; 2021 (Parentage, %)
Table 1: Characteristics of Existing Proteomics Technologies
Table 2: High Plex Proteomic Comparison
Table 3: Global Proteomics Market Players: Technology Comparison

この商品のレポートナンバー

0000033720

TOP